Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells.
about
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyondEctopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion.Dendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic miceDendritic cell-based human immunodeficiency virus vaccine.RNA as performance-enhancers for dendritic cells.Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.Immunotherapy for head and neck cancer patients: shifting the balance.mRNA-based dendritic cell vaccines.mRNA transcript therapy.Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen.Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses.Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory propertiesType 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.mRNA vaccines - a new era in vaccinology.Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses
P2860
Q26861563-AE6FC070-3173-45AB-BECC-B98720BC420EQ33377577-8F38E7DB-5EAA-41E2-93D7-3ADF1AC72C4EQ33522216-A007ADC2-C286-4935-855C-875BE679E4FBQ33874652-1F61C0EF-01EE-4668-992F-987216A8A302Q37686532-C73CABC7-E6A6-44E3-831E-30B69AF50F0EQ38031222-C02C7324-8A35-4372-B0BE-9BC3E01809A1Q38068966-132E6088-D95C-4874-B450-C7EF80A23FE4Q38246769-1329B3C8-FB92-46CF-8271-C86557C5F3DDQ38264088-95C7EBDE-3C85-4E42-ACF2-01967BA76F85Q38848780-C8FF7753-4137-4B3D-BA64-07A185AD08F7Q39547016-9BDC858C-69D2-46D5-99D3-1EA921677604Q39550595-53CDD046-CE06-43CB-8A68-1E6366C83B9AQ41503180-DD934DD6-5DC7-4E25-B46F-EFD5A079CC82Q41945985-0A429F7E-94E0-4F8A-968F-8B19BAB44089Q43196387-1126E6F5-E164-4C05-9A5C-3E779FF582F4Q47736893-8D52BD69-2B88-4250-B85A-5CAA7815BD00Q56967539-6027EA84-49BA-4B0B-B46B-F0E1464051C9
P2860
Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Dendritic cells transfected wi ...... igh avidity cytotoxic T cells.
@en
Dendritic cells transfected wi ...... igh avidity cytotoxic T cells.
@nl
type
label
Dendritic cells transfected wi ...... igh avidity cytotoxic T cells.
@en
Dendritic cells transfected wi ...... igh avidity cytotoxic T cells.
@nl
prefLabel
Dendritic cells transfected wi ...... igh avidity cytotoxic T cells.
@en
Dendritic cells transfected wi ...... igh avidity cytotoxic T cells.
@nl
P2093
P2860
P356
P1433
P1476
Dendritic cells transfected wi ...... high avidity cytotoxic T cells
@en
P2093
Bontkes HJ
Ruizendaal JJ
P2860
P2888
P304
P356
10.1038/SJ.GT.3302874
P577
2006-10-12T00:00:00Z
P5875
P6179
1049088276